NCT04936308 2026-03-12SOLSTICEJanssen Research & Development, LLCPhase 3 Active not recruiting453 enrolled 25 charts
NCT04948398 2025-02-03Post-Trial Access for Guselkumab in Participants With Familial Adenomatous PolyposisJanssen Research & Development, LLCNo longer available
NCT03162796 2021-02-03Discover-1Janssen Research & Development, LLCPhase 3 Completed383 enrolled 106 charts